Pharmacotherapy considerations in transgender individuals living with human immunodeficiency virus

Pharmacotherapy. 2021 Mar;41(3):299-314. doi: 10.1002/phar.2499. Epub 2021 Feb 27.

Abstract

Pharmacotherapy considerations are often a concern for transgender individuals who are living with human immunodeficiency virus (HIV) due to concerns for drug-drug interactions between their hormone and antiretroviral therapies. Many of the first-line therapies offered to patients for the management of HIV have reduced concerns for safety, resistance, and drug-drug interactions. In this review, we highlight common medications and important considerations for caring for transgender people living with HIV.

Keywords: antiretroviral therapy; hormone therapy; human immunodeficiency virus; transgender.

Publication types

  • Review

MeSH terms

  • Drug Interactions
  • Female
  • HIV Infections* / drug therapy
  • Humans
  • Male
  • Transgender Persons*